| Source: |
| Type: |
| Tumor Cell Colony Formation |
| 9018- | 3BP, | C-Phycocyanin exerts anti-cancer effects via the MAPK signaling pathway in MDA-MB-231 cells |
| - | in-vitro, | BC, | MDA-MB-231 |
| 9234- | AITC, | BITC, | PEITC, | Allyl-, Butyl- and Phenylethyl-Isothiocyanate Modulate Akt–mTOR and Cyclin–CDK Signaling in Gemcitabine- and Cisplatin-Resistant Bladder Cancer Cell Lines |
| - | in-vitro, | Bladder, | NA |
| 9246- | ISO, IH, | Isorhamnetin inhibits migration and promotes apoptosis via modulation of oxidative stress, mitochondrial dysfunction, and the TIGIT/CD155 axis in 4T1 breast cancer cells |
| - | in-vitro, | BC, | 4T1 |
| 9245- | ISO, IH, | Autophagy inhibition enhances isorhamnetin‑induced mitochondria‑dependent apoptosis in non‑small cell lung cancer cells |
| - | in-vitro, | Lung, | A549 |
| 8954- | mushLions, | Hericium erinaceus polysaccharide-protein HEG-5 inhibits SGC-7901 cell growth via cell cycle arrest and apoptosis |
| - | in-vitro, | GC, | SGC-7901 |
| 9044- | PatchO, | Patchouli oil and its main component patchouli alcohol inhibit colorectal cancer by activating ectopic olfactory receptor |
| - | vitro+vivo, | CRC, | HCT116 |
| 9048- | PatchO, | Patchouli alcohol induces G0 /G1 cell cycle arrest and apoptosis in vincristine-resistant non-small cell lung cancer through ROS-mediated DNA damage |
| - | in-vitro, | Lung, | A549 |
| 9029- | Phyco, | Advances about the study of phycocyanin in the treatment of breast cancer: A review |
| - | Review, | BC, | NA |
| 9017- | Phyco, | Molecular mechanism of anti-cancer activity of phycocyanin in triple-negative breast cancer cells |
| - | in-vitro, | BC, | MDA-MB-231 | - | in-vitro, | BC, | MCF7 |
| 9014- | Phyco, | C-Phycocyanin Suppresses the In Vitro Proliferation and Migration of Non-Small-Cell Lung Cancer Cells through Reduction of RIPK1/NF-κB Activity |
| - | in-vitro, | Lung, | H1650 |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:0 prod#:% Target#:1906 State#:% Dir#:1
wNotes=0 sortOrder:rid,rpid